Navigation Links
Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results
Date:11/4/2009

PURCHASE, N.Y., Nov. 4 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. (OTC Bulletin Board: NXXI), the developer and marketer of ingredients and finished products under the Iceland Health®, Chromax®, and Diabetes Essentials®( )brands that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory and reduce chronic joint pain, today announced financial results for the first quarter of fiscal year 2010 ended September 30, 2009.

The Company reported total revenues of $4.6 million for the first quarter ended September 30, 2009, compared to $12.7 million in the corresponding quarter a year ago. Net loss for the first quarter this year was $0.6 million, or $(0.01) per diluted common share, compared to net income of $0.2 million, or $0.00 per diluted common share, in the first quarter a year ago.

The Company's continuing emphasis on controlling its expenses reduced operating expenses by $3.9 million, or 62%, from $6.3 million in the first quarter last year to $2.4 million in the first quarter this year. The reduction in expenses was the primary reason for the Company's $0.4 million operating profit for the first quarter of this fiscal year.

Michael Zeher, president and chief executive officer, said, "While economic conditions continue to be extremely challenging, we are aggressively managing our expenses and, as a result, were profitable on an operating basis in the first quarter. We also continue to work diligently to arrange new financing to replace the current line that we will pay off on November 15, 2009. Moreover, we continue to work with the Iceland Health principals to reach an accommodation on the $2.5 million plus interest that we owe them and secured with the Iceland Health trademark."

"Additionally, in the first quarter we signed a non-binding letter of intent for the sale of certain assets and liabilities of our retail and direct response businesses to a priva
'/>"/>

SOURCE Nutrition 21, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. IOM recommends new nutritional requirements for school meal programs
2. Fitness Nutritions Amino Acid Complex Olympic Champion Dara Torres Calls The Best Product Ive Ever Used, Selects TransMedia for PR
3. For Older Adults, Good Nutrition and Exercise Are Key To Staying Healthy & Active
4. Nutrition Still Not A Grade in U.S. Schools: Studies
5. Bariatric Advantage Re- Launches ProMend ABG Designed to Nutritionallly Support Pre and Post Plastic Reconstructive Surgery Patient
6. Compatible Technology International Project to Enhance Child Nutrition and Livelihoods of Rural Families in Malawi and Tanzania
7. Protica Teams With UNFI/Select Nutrition to distribute All-Natural Protein Shot, Proasis
8. Innovative New Book Series Encourages Kids to Go Behind Their Parents' Backs and Listen to Experts on Important Health and Wellness, Education, Personal Finance and Nutrition
9. Senior Living Residences Launches Innovative Nutrition Program to Promote Cognitive Health and Lower the Risk of Alzheimers Disease
10. Frost & Sullivan Cites Arm & Hammer for Excellence in the Dairy Animal Nutrition and Management Market
11. People with type 2 diabetes not meeting important nutritional recommendations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , PALO ALTO, Calif., Dec. 4 /PRNewswire-Fi...announced today that its Board of Directors has se...for February 11, 2010 with a record date of Decemb...e Plaza Cabana Hotel, 4290 El Camino Real, Palo Al...will be webcast by Thomson Financial and can be ac...
(Date:12/4/2009)..., NEW YORK, Dec. 4 Thousands of ...ffices nationwide today, to participate in a commu...nd advisory firm,s support for literacy with chari...flects our firm,s long history of volunteerism. In...n the spirit of caring to brighten the holidays fo...
(Date:12/4/2009)..., PEMBROKE, Bermuda, Dec. 4 /PRNewswire-Firs... Ltd (NYSE: AWH ) today announced that Scott Car... Jack Sennott, Executive Vice,President and Chief ...the 2009,Goldman Sachs U.S. Financial Services Con... Center in New York City on Tuesday, December 8, 2...
(Date:12/4/2009)..., SCOTTSDALE, Ariz., Dec. 4 Health...d, non-traded, real estate investment trust, annou...t to acquire a three building medical office portf...s, and Fort Wayne, Indiana for approximately $20,5... to the satisfaction of a number of conditions. ,...
(Date:12/4/2009)... , MADISON HEIGHTS, Mich., Dec. 4 /PRNewsw...ew Committee of BetterInvesting Magazine today a...bruary 2010 "Stock to Study" and C.R. Bard, Inc. ...Stock" for investors, informational and educationa... of growth opportunities involving its flagship dr...
Breaking Medicine News(10 mins):Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2
...ay,September 15, will mark the first national "Sho...on, MD-based nonprofit patient advocacy,group, wil...ington, DC to,celebrate. From noon to 2 pm at Port...vent is free but donations are,requested. More inf...
...nic Obstructive Lung Disease (GOLD) has released n...vention of chronic obstructive pulmonary disease (...portance of proper diagnosis, assessment of the di...ine, but this is the first complete makeover since...
...in Access To Premier Research Platform Cus...s, CHENNAI, India, Sept. 14 Thomson Scientific,p...TOC) and leading provider,of information solutions...son Scientific,s ISIWeb of Knowledge,platform to s...
...ast 10 years at the huge TAS rotorcraft ...TH, Texas, Sept. 13 Texas Aviation Services, an,i...on, MRO and maintenance,services for over 36 years...show (Air Medical Transport Conference,sponsored b...
...coated model is safer , , THURSDAY, Sept. ...coated stents finds that those coated with the med... those coated with another drug, paclitaxel. , Ana... at the entire picture," said lead researcher Dr. ...
...ernational,Inc. (Nasdaq: ARRO ) today sent anothe... on the WHITE proxy card for its planned $45.50 me...to re-elect the Arrow Board of,Directors, who are ... The Annual Meeting is on September 20, 2007. The...
Other Medicine News:Health News:DC Psoriasis Event Saturday Will Celebrate First National Short Sleeve Day 2Health News:Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD 2Health News:Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR) 2Health News:Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR) 3Health News:Texas Aviation Services: Over 20 Years of Creating 'Flying Emergency Rooms' for Airborne EMS Customers in US and Latin America 2Health News:Drug-Coated Stents Go Head to Head 2Health News:Drug-Coated Stents Go Head to Head 3Health News:Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors 2Health News:Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors 3Health News:Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors 4
(Date:12/4/2009)..., Opposes use of imported drugs often stored .... 4 Today, the senior a...t the Dorgan Importation plan encompassed in SA 27...ator Dorgan,s importation amendment is poised to o...stem to be breached, and our health to be endanger...
(Date:12/4/2009)... , MORRISTOWN, N.J., Dec. 4 /PRNewswire-First... ), a leading global specialty pharmaceutical comp...aboratories, Inc.-Florida, filed an Abbreviated Ne...rug Administration seeking approval to market its ... patent owned by Takeda Pharmaceutical Company Lim...
(Date:12/4/2009)... , RARITAN, N.J., Dec. 4 Depre...on Deficit Hyperactivity Disorder (ADHD), sleep di...ties reported to occur more often in people who sa...ose without an epilepsy diagnosis, according to a ...the U.S. ,, Findings from " CNS-Related Comorbi...
Breaking Medicine Technology:RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Major clinical study rejects cancer safety fears of most common heartburn treatment 56590 1Major clinical study rejects cancer safety fears of most common heartburn treatment 56590 2Lead in bone associated with increased risk of death from cardiovascular disease in men 56585 1Lead in bone associated with increased risk of death from cardiovascular disease in men 56585 2Getting plants to rid themselves of pesticide residues 9840 1
... 2007 /PRNewswire-FirstCall/ --,Genzyme Corp. anno...ase 3 clinical studies to assess the safety and ef...n-antibiotic, polymer,therapy for patients with Cl...e second Phase 3 study of tolevamer liquid is full...r. , In this first Phase 3 study known as the Poly...
...ESS WIRE)--Jul 9, 2007 - ZIOPHARM,Oncology, Inc. (...,from an ongoing phase II trial of ZIO-201 (isopho...a patients was presented at the,European Society o...007 in Lugano, Switzerland. The abstract entitled,...rcoma," was presented by,Rashmi Chugh, MD, a Princ...
Other Medicine Technology:Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 2Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 3Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 4Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
Heavy Duty Locking Pliers
Delicate Wire Cutter
Osteotome
...tomap is the companys core product. It is created ...l eye care for the screening of eye and non-eye di...-patient examination basis and is non-reimbursable...ital wide-field of view of the patients retina whi...
Medicine Products: